Market Access Still A Problem In Saudi Drug Sector

May 2006 | Market Trend Analysis

However, the new law was implemented retroactively, thus hundreds of patent applications were summarily rejected. As a result, PhRMA is asking officials not to apply the law in retrograde. To further complicate matters, a number of generic versions of drugs have been approved, while patent applications for the original drug were being processed, demonstrating the lack of an effective patent linkage system in the

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.